We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -20.00 | -0.16% | 12,106.00 | 12,120.00 | 12,122.00 | 12,190.00 | 12,024.00 | 12,080.00 | 999,558 | 16:35:02 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 45.81B | 5.96B | 3.8415 | 31.55 | 187.98B |
Hot Features
Premium
RNS Number:1531R
AstraZeneca PLC
22 October 2003
AstraZeneca's third quarter and nine months results 2003
Tomorrow, Thursday, 23 October 2003 AstraZeneca will be releasing its third
quarter and nine months results for 2003 at 11:00 BST.
There will be an analyst teleconference at 13:30BST, 08:30 EST, for which the
numbers are in the UK: 0800 279 9640, for Europe +44 (0)20 7019 9504 and for
the US: 1 866 850 2201 . These numbers, as well as details of the replay
facility available through Monday, 3 November 2003, are on the Investor
Relations part of the AstraZeneca website at www.astrazeneca.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORILFIDISLLFIV
1 Year Astrazeneca Chart |
1 Month Astrazeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
